Study Conduct

PSI, Synta Pharmaceuticals collaborate on trial

Tuesday, March 5, 2013 04:00 PM

Switzerland-based CRO PSI said it has been selected by Synta Pharmaceuticals to conduct its GALAXY-2 trial, a randomized, phase III study of Ganetespib in combination with Docetaxel versus Docetaxel alone in patients with advanced non-small cell lung cancer.  PSI currently is initiating this 500-patient study across 15-plus countries.

More... »

Xceleron, Kinetigen partner to simplify phase I investigations

Tuesday, February 26, 2013 09:06 AM

Xceleron, a provider of bioanalytical AMS services for accelerated early drug development, has formed a partnership with Kinetigen, a clinical pharmacology consulting firm specializing in pharmacokinetics. The partnership will offer drug developers simpler and more robust early clinical investigations.

More... »

ELC Group launches clinical trials services

Friday, February 22, 2013 10:19 AM

ELC Group, a provider of regulatory affairs consulting services, has launched a new clinical trials service for pharmaceutical customers worldwide.

More... »

CTTI forms patient leadership council to drive improvements in clinical trials

Friday, February 15, 2013 10:50 AM

 As part of an effort to improve the way clinical trials are conducted, the Clinical Trials Transformation Initiative (CTTI), a public-private partnership to identify practices to increase the quality and efficiency of clinical trials, has formed a 16-member council to engage patient advocates in its mission.

More... »

Genetically engineered virus extends lives of terminally-ill liver cancer patients

Wednesday, February 13, 2013 03:01 PM

A genetically-engineered virus has prolonged the lives of terminally ill liver cancer patients in a small clinical trial, according to the findings published in Nature Medicine. The results will need confirming in larger studies, but Cancer Research U.K. welcomed the advance as "an exciting step forward."

More... »

GSK supports AllTrials campaign for clinical data transparency

Wednesday, February 6, 2013 10:14 AM

GlaxoSmithKline (GSK) has further demonstrated its commitment to clinical trial transparency by announcing its support for the AllTrials campaign. The campaign is calling for registration of clinical trials and the disclosure of clinical trial results and clinical study reports (CSRs) to help drive further scientific understanding.

More... »

Medical societies to launch large-scale study on vein filter use

Monday, February 4, 2013 11:56 AM

The Society of Interventional Radiology (SIR) and Society for Vascular Surgery (SVS) jointly will launch PRESERVE—the first large-scale, multi-specialty prospective study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment.

More... »

Cardon Children's, Banner Research to conduct pediatric cancer trials

Friday, February 1, 2013 10:19 AM

Banner Children's at Cardon Children's Medical Center has partnered with Banner Research to be approved as a Children's Oncology Group (COG) Institution. This designation partners both groups to provide infrastructure to conduct pediatric clinical cancer trials at Cardon Children's.

More... »

ActiGraph launches ActiLife Mobile app

Tuesday, January 15, 2013 10:32 AM

Pensacola, Fla.-based ActiGraph, a provider of objective patient monitoring solutions for the global research community, has released a new mobile app for researchers.

More... »

Cerner, Icon partner to streamline late-phase research studies

Monday, January 14, 2013 09:14 AM

Cerner, a global innovator in electronic health record (EHR) and research technology, and global CRO Icon have formed an agreement to provide pharmaceutical and device sponsors with late-phase research technology to streamline the collection of information related to the safety, effectiveness and value of their medical products.

More... »